Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Jobs
Investors
Funding rounds
Exits
New startups
Investment heatmap
Themes
Matching tool
Blog
Reports
Companies
Perception Neuroscience
Save
Perception Neuroscience
Unverified
We are developing PCN-101 (Arketamine, or R-ketamine) with a vision of providing solutions to mental health disorders
Launch date
2018
Employees
2-10 people
New York City New York (HQ)
https://www.perceptionns.com/
https://www.linkedin.com/company/perception-neurosciences/
B2B
manufacturing
commission
health
biotechnology
biotech and pharma
psychedelic drugs
Overview
Similar companies
Analytics
Notes
Jobs (0)
Innovations (0)
Patents
RELATED LANDSCAPES AND LISTS
Perception Neuroscience funding
Perception Neuroscience investors
Edit
Date
Investors
Amount
Round
Mar 2020
WPSS.bio
N/A
Convertible
Not yet verified
Total Funding
-
Recent News about Perception Neuroscience
Edit